Alexandria Real Estate Equities
ARE
#2431
Rank
A$11.06 B
Marketcap
A$63.51
Share price
-0.02%
Change (1 day)
-18.62%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -A$1.43 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.67 Billion. In 2025 the company made an earning of -A$1.49 Billion a decrease over its 2024 earnings that were of A$1.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.43 Billion-3.65%
2025 -A$1.49 Billion-242.13%
2024 A$1.04 B96.11%
2023 A$0.53 B-53.56%
2022 A$1.14 B-3.96%
2021 A$1.19 B-20.26%
2020 A$1.49 B72.88%
2019 A$0.86 B3.11%
2018 A$0.83 B73.54%
2017 A$0.48 B464.88%
2016 A$85.67 M-77.32%
2015 A$0.37 B36.31%
2014 A$0.27 B-10.81%
2013 A$0.31 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.44 B-825.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.11 B-3,719.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.56 B-1,250.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.8 Billion 163.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.67 B-216.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.98 B-1,279.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.83 B-227.16%๐Ÿ‡บ๐Ÿ‡ธ USA